Article
Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
Journal of microbiological methods - 1 Aug 2017
Pérez-García F, Ruiz-Serrano M J, López Roa P, Acosta Fermín, Pérez-Lago Laura, García-De-Viedma D, Bouza E
Abstract excerpt
PURPOSE: Genotypic methods have considerably improved the diagnosis of multidrug-resistant (MDR) tuberculosis. One of these tests is Anyplex II MTB/MDR/XDR (Anyplex). Our aim was to evaluate the diagnostic performance of this multiplex PCR. METHODS: We conducted our study on 47 MDR tuberculosis and 14 pan-susceptible strains. We evaluated the ability of Anyplex to detect resistance mutations in rpoB (rifampin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
